Villarin, Lorna .
HRN: 24-40-40 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/05/2024
CEFUROXIME 500MG (TAB)
06/05/2024
06/12/2024
PO
1 Tablet
BID
S/P NSVD With 2nd Degree RMLE And Repair
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes